Our previous study reveals that FLT3-ITD and MLL-AF9 oncogenes, which present with a high leukemic burden and confer a poor prognosis in patients with AML, contributed to the silencing of GADD45g in AML10. Here, MLLT3 is linked to acute myeloid leukemia.